Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
General transcription factor IIIC subunit 1 (GTF3C1) is a core component of the TFIIIC multiprotein complex, crucial for the initiation of transcription of small noncoding RNA genes—including tRNA and 5S rRNA genes—by RNA polymerase III. GTF3C1 recognizes internal promoter elements and helps recruit the Pol III machinery to its targets. The protein integrates signals from nutrient and stress-related pathways, notably through interactions with kinases such as mTOR and chromatin regulators like SIRT7, thereby linking cellular metabolic state to ribosome biogenesis and protein synthesis. Disruption or dysregulation of GTF3C1 may contribute to altered growth or tumor biology due to its pivotal role in controlling the transcription of components required for protein translation[1][2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIIC subunit 1 (GTF3C1).